• 1
    Matteoni CA, Younossi ZM, Gramlich T, Boparal N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 14131419.
  • 2
    McCullough AJ. The epidemiology and risk factors of NASH. In: FarrellGC, GeorgeJ, HallP de la M, McCulloughAJ, eds. Fatty Liver Disease. NASH and Related Disorders. Blackwell Publ Ltd. Malden, 2005: 2337.
  • 3
    Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C, et al.. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. HEPATOLOGY 2002; 35: 373379.
  • 4
    Sanyal AJ. The pathogenesis of NASH: human studies. In FarrellGC, GeorgeJ, HallP de la M, McCulloughAJ, eds. Fatty liver disease: NASH and related disorders. Blackwell Publ Ltd. Malden, 2005: 7690.
  • 5
    Chitturi S, Farrell GC. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis 2001; 21: 2741.
  • 6
    James O, Day CP. Non-alcoholic steatohepatitis: another disease of affluence. Lancet 1999; 353: 16341636.
  • 7
    Fromenty B, Robin MA, Igoudjil A, Mansouri A, Pessayre D. The ins and outs of mitochondrial dysfunction in NASH. Diabetes Metab 2004; 30: 121138.
  • 8
    Pérez-Carreras M, Del Hoyo P, Martín MA, Rubio JC, Martín A, Castellano G, et al. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. HEPATOLOGY 2003; 38: 9991007.
  • 9
    Koteish A, Diehl AM. Animal models of steatosis. Semin. Liver Dis 2001; 21: 89104.
  • 10
    Farrell GC. Animal models of steatohepatitis. In: FarrellGC, GeorgeJ, HallP de la M, McCulloughAJ, eds. Fatty liver disease: NASH and related disorders. Malden: Blackwell Publ Ltd., 2005: 91108.
  • 11
    Radi R, Cassina A, Hodara R, Castro L. Peroxynitrite reactions and formation in mitochondria. Free Radic Biol Med 2002; 33: 14511464.
  • 12
    Brown GC, Cooper CE. Nanomolar concentrations of NO reversibly inhibit sypnaptosomal respiration by competing with oxygen at cytochrome oxidase. FEBS Lett 1994; 356: 295298.
  • 13
    Radi R, Cassina A, Hodara R. Nitric oxide and peroxynitrite interactions with mitochondria. Biol Chem 2002; 383: 401409.
  • 14
    Guidarelli A, Fiorani M, Cantoni O. Enhancing effects of intracellular ascorbic acid on peroxynitrite-induced U937 cell death are mediated by mitochondrial events resulting in enhanced sensitivity to peroxynitrite-dependent inhibition of complex III and formation of hydrogen peroxide. Biochem J 2004; 378: 959966.
  • 15
    Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite oxidation of sulfhydryls: the cytotoxic potential of superoxide and nitric oxide. J Biol Chem 1991; 266: 42444250.
  • 16
    Szabó C. DNA strand breakage and activation of poly-ADP ribosyltransferase:a cytotoxic pathway triggered by ONOO. Free Radic Biol Med 1996; 21: 855869.
  • 17
    Viner RI, Williams TD, Schoneich C. Peroxynitrite modification of protein thiols: oxidation, nitrosylation, and S-glutathiolation of functionally important cysteine residue(s) in the sarcoplasmic reticulum Ca-ATPase. Biochemistry 1999; 38: 1240812415.
  • 18
    Hooper DC, Scott GS, Zborek A, Mikheeva T, Kean RB, Koprowski H, et al. Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis. FASEB J 2000; 14: 691698.
  • 19
    Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001; 120: 11831192.
  • 20
    Crane DI, Kalish JE, Gould SJ. The Pichia Pastoris PAS4 gene encodes an ubiquitin-conjugating enzyme required for peroxisome assembly. J Biol Chem 1994; 269: 2183521844.
  • 21
    Watkins PA, Ferrell EV Jr, Pedersen JI, Hoefler G. Peroxisomal fatty acid β-oxidation in HepG2 Cells. Arch Biochem Biophys 1991; 289: 329336.
  • 22
    Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351358.
  • 23
    Eady JJ, Osta T, Dennis MF, Stratford MR, Peacock JH. Glutathione determination in the Tietze enzymatic recycling assay and its relationship to cellular radiation response. Br J Cancer 1995; 72: 10891095.
  • 24
    Santiago B, Galindo M, Palao G, Pablos JL. Intracellular regulation of Fas-induced apoptosis in human fibroblasts by extracellular factors and cycloheximide. J Immunol 2004; 172: 560566.
  • 25
    Turko IV, Marcondes S, Murad F. Diabetes-associated nitration of tyrosine and inactivation of succinyl-CoA:3-oxoacid CoA-transferase. Am J Physiol Heart Circ Physiol 2001; 281: H2289H2294.
  • 26
    Lang A, Schrum L, Schoonhoven R, Tuvia S, Solis-Herruzo JA, Tsukamoto H, et al. Expression of the small heat shock protein αb-crystallin is induced after hepatic stellate cells activation. Am J Physiol 2000; 279: G1333G1342.
  • 27
    Moldeus P, Högberg J, Orrenius S. Isolation and use of liver cells. Methods Enzymol 1978; 52: 6070.
  • 28
    Zwerina J, Hayer S, Tohidast-Akrad M, Bergmeister H, Redlich K, Feige U, et al. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis. Arthritis Rheum. 2004; 50: 277290
  • 29
    Hatano E, Bennett BL, Manning AM, Qian T, Lemasters JJ, Brenner DA. NF-κB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNFα- and Fas-mediated apoptosis. Gastroenterology 2001; 120: 12511262.
  • 30
    Whiteman M, Ketsawatsakul U, Halliwell B. A reassessment of the peroxynitrite scavenging activity of uric acid. Ann N Y Acad Sci 2002; 242259.
  • 31
    Spahr L, Negro F, Leandro G, Marinescu O, Goodman KJ, Rubbia-Brandt L, et al. Impaired hepatic mitochondrial oxidation using the 13C-methionine breath test in patients with macrovesicular steatosis and patients with cirrhosis. Med Sci Monit 2003; 9: CR611
  • 32
    Cortez-Pinto H, Chatham J, Chacko VP, Arnold C, Rashid A, Diehl AM. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. JAMA 1999; 282: 16591664
  • 33
    Li Z, Yang S, Lin H, Huang J, Watkins PA, Moser AB, et al. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. HEPATOLOGY 2003; 37: 343350.
  • 34
    Chen J, Petersen DR, Schenker S, Henderson GI. Formation of malondialdehyde adducts in livers of rats exposed to ethanol: role in ethanol-mediated inhibition of cytochrome c oxidase. Alcohol Clin Exp Res 2000; 24: 544552.
  • 35
    Demeilliers C, Maisonneuve C, Grodet A, Mansouri A, Nguyen R, Tinel M, et al. Impaired adaptive resynthesis and prolonged depletion of hepatic mitochondrial DNA after repeated alcohol binges in mice. Gastroenterology 2002; 123: 12781290
  • 36
    Haque M, Mirshahi F, Campbell-Sargent C, Sterling RK, Luketic VA, Shiffman M, et al. Nonalcoholic steatohepatitis (NASH) is associated with hepatocytes mitochondrial DNA depletion [Abstract]. HEPATOLOGY 2002; 36(Suppl): A403.
  • 37
    Sánchez-Alcázar JA, Schneider E, Martínez MA, Carmona P, Hernández-Muñoz I, Siles E, et al. Tumor necrosis factor-α increases the steady state reduction of cytochrome b of the mitochondrial respiratory chain in metabolically inhibited L929 cells. J Biol Chem 2000; 275: 1335313361.
  • 38
    Higuchi M, Proske RJ, Yeh ET. Inhibition of mitochondrial respiratory chain complex I by TNF results in cytochrome c release, membrane permeability transition, and apoptosis. Oncogene 1998; 17: 25152524.
  • 39
    Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J. Beyond insulin resistance in NASH: TNFα or adiponectin? HEPATOLOGY 2004; 40: 4654.
  • 40
    Kern PA, Saghizadeh M, Org JM, Bosch RJ, Deem R, Simsolo RB. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 1995; 95: 21112119.
  • 41
    Crespo J, Cayon A, Fernández-Gil P, Hernández-Guerra M, Mayorga M, Domínguez-Diez A, et al. Gene expression of tumor necrosis factor-α and TNF-receptors, p55 and p75, in non-alcoholic fatty liver disease. HEPATOLOGY 2001; 34: 11581163.
  • 42
    Feldstein AE, Werneburg NW, Canbay A, Guicciardi ME, Bronk SF, Rydzewski R, et al. Free fatty acids promotes hepatic lipotoxicity by stimulating TNFα expression via a lysosomal pathway. HEPATOLOGY 2004; 40: 185194.
  • 43
    Nguyen MTA, Satoh H, Favelyukis S, Babendure JL, Imamura T, Sbodio JI, et al. JNK and tumor necrosis factor-α mediate free fatty acid-induced insulin resistance in 3T3–L1 adipocytes. J Biol Chem 2005; 280: 3536135371.
  • 44
    Curran RB, Billiar TR, Stuehr DJ, Hoffmann K, Simmons RL. Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells. J Exp Med 1989; 170: 17691774.
  • 45
    Giulivi C, Poderoso JJ, Boveris A. Production of nitric oxide in mitochondria. J Biol Chem 1998; 273: 1103811043.
  • 46
    Laurent A, Nicco C, Van Nhieu JT, Borderie D, Chéreau C, Conti F, et al. Pivotal role of superoxide anion and beneficial effect of antioxidant molecules in murine steatohepatitis. HEPATOLOGY 2004; 39: 12771285.
  • 47
    MacMillan-Crow LA, Crow JP, Thompson JA. Peroxynitrite-mediated inactivation of manganese superoxide dismutase involves nitration and oxidation of critical tyrosine residues. Biochemistry 1998; 37: 16131622.
  • 48
    Kuzkaya N, Weissmann N, Harrison DG, Dikalov S. Interactions of peroxynitrite with uric acid in the presence of ascorbate and thiols: implications for uncoupling endothelial nitric oxide synthase. Biochem Pharm 2005; 70: 343354.
  • 49
    Murray J, Taylor SW, Zhang B, Ghosh SS. Oxidative damage to mitochondrial complex I due to peroxynitrite. J Biol Chem 2003; 278: 3722337230.
  • 50
    Chou SM, Wang HS, Taniguchi A. Role of SOD-1 and nitric oxide/cyclic GMP cascade on neurofilament aggregation in ALS/MND. J Neurol Sci 1996; 139(Suppl): 626.